Akebia Therapeutics
AKBA
#6958
Rank
โ‚น34.42 B
Marketcap
โ‚น163.69
Share price
4.02%
Change (1 day)
115.89%
Change (1 year)

Akebia Therapeutics (AKBA) Fails to deliver data

Key failure to deliver metrics for Akebia Therapeutics:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Akebia Therapeutics (AKBA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Akebia Therapeutics (AKBA) - since 2014

Volume in USD (price x number of shares), data since 2014

Akebia Therapeutics (AKBA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024โ‚น4.58 M70.9%
2023โ‚น2.68 M-41.28%
2022โ‚น4.56 M8.92%
2021โ‚น4.19 M-18.58%
2020โ‚น5.15 M43.43%
2019โ‚น3.59 M-62.25%
2018โ‚น9.51 M238.71%
2017โ‚น2.8 M-25.14%
2016โ‚น3.75 M92.2%
2015โ‚น1.95 M-88.22%
2014โ‚น16.56 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
โ‚น56.79 Mโ‚น0.30 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น16.44 Mโ‚น78.49 M๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚น70.4 Mโ‚น0.32 B๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.03 Mโ‚น0.15 M๐Ÿ‡บ๐Ÿ‡ธ USA